Nixon Vanderhye’s pharmaceuticals team assists pharmaceutical companies in developing and protecting their IP assets throughout the entire drug product life cycle. All our team members have extensive legal and technical experience. This ensures that our clients’ projects are handled only by tenured attorneys who understand the clients’ business and industry, and who are best positioned to help clients protect the intellectual property underlying their new drugs and treatments so they may achieve their near- and long-term business goals. Most of the attorneys in our pharmaceuticals team have advanced degrees in chemistry, biology, or closely related fields, and the majority hold Ph.D. credentials. Our attorneys have worked in global pharmaceutical and biotechnology companies, serving in legal, research and development, corporate, and/or business development roles. We understand the global aspects of the pharmaceutical business and routinely work with clients to develop global IP strategies to align with their global business needs.

Our clients include those developing new chemical entities, repositioning known drugs, developing new manufacturing processes, and/or developing various drug discovery and development tools.


Nixon Vanderhye’s experience in pharmaceutical technologies includes:

  • New Chemical Entities
    • Synthetic Compounds
    • Natural Products and Derivatives
  • Drug Repositioning
    • Prodrugs
    • Combinations
    • New Indications
    • New Pharmacokinetics
    • Targeted Drug Delivery
    • Precision Medicine
  • Manufacturing
    • Synthetic Chemistry
    • Polymorphs and Co-Crystals
    • Purification
    • Formulation
  • Drug Discovery and Development Tools
    • Combinatory Chemistry
    • Drug Screening Assays
    • Drug Design Platforms
    • Catalysis and Reactors

Our turnkey services include patent preparation and prosecution, both domestically and worldwide; freedom to operate, patentability, non-infringement, and invalidity opinions; appeals; post-grant proceedings; reexaminations; and reissues. In addition, we provide strategic portfolio management to assist clients in developing patent portfolios that cover the entire pharmaceutical life cycle with maximized patent term. We also routinely provide counsel on IP due diligence, research collaborations, and technology-driven transactions.